{"name":"Ophthalmic Consultants of Long Island","slug":"ophthalmic-consultants-of-long-island","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Cyclosporine 0.05%","genericName":"Cyclosporine 0.05%","slug":"cyclosporine-0-05","indication":"Dry eye disease (keratoconjunctivitis sicca)","status":"marketed"},{"name":"Ocular lubricant","genericName":"Ocular lubricant","slug":"ocular-lubricant","indication":"Dry eye syndrome / Keratoconjunctivitis sicca","status":"marketed"}]}],"pipeline":[{"name":"Cyclosporine 0.05%","genericName":"Cyclosporine 0.05%","slug":"cyclosporine-0-05","phase":"marketed","mechanism":"Cyclosporine is a calcineurin inhibitor that suppresses T-cell activation and reduces inflammatory cytokine production in the eye.","indications":["Dry eye disease (keratoconjunctivitis sicca)"],"catalyst":""},{"name":"Ocular lubricant","genericName":"Ocular lubricant","slug":"ocular-lubricant","phase":"marketed","mechanism":"Ocular lubricants reduce friction and provide moisture to the ocular surface by forming a protective film over the cornea and conjunctiva.","indications":["Dry eye syndrome / Keratoconjunctivitis sicca","Ocular surface irritation and discomfort"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPYkFkcnZPbVI5UmZYSzg5S1RlbUE0UjZKVkNlVTlab1NJR2gxdjRxVG9uM1VlOURjcDFmSWhxalFmLVM4ZVBoWUNkZXVWZjRGdkNtRldlVV9JbUNXQ29GcXpGemZER3JZdURoWEVuamdMTVhHWWlTQVpyMzJIOUpBMGlURUxzYmdLMlVUa1NlLW4tUmZQOERyY3RmSWVTMEtfTXJYaVRuYXliWXIxdnFPMm50Y1ZiN2ZETVE?oc=5","date":"2026-02-27","type":"pipeline","source":"Eyes On Eyecare","summary":"Case reports indicate positive outcomes of CAM for OSD management - Eyes On Eyecare","headline":"Case reports indicate positive outcomes of CAM for OSD management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOdVE3cnMxdkwtdGx1Q1B6ZFVCeFdfa0FiTzdCdHhfVk45V0tDUmdwUG8xZzV2ZjhDdHU2MVVzblpKdUU3V2l2OGgwWUVyRkdDcUlhdUxfdERIdjVicXhXMHA4cUR0YjFoZm84TlVvR1d6WnJCdTFDSDRLREFpbWMtQTl2MUhLNWwwNks1Q25Yb2duVkdMVkY3RVJyUQ?oc=5","date":"2024-11-13","type":"pipeline","source":"Ophthalmology Times","summary":"New canalicular gel shows promise for dry eye treatment - Ophthalmology Times","headline":"New canalicular gel shows promise for dry eye treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQRmsyb0lCS01qdTdiOTh3cFN0bjlhS1dhQnZBUnlEWFJnZDVmdjRfdVBBSDNzX2xKcm1EUGhadUg3ZmRmSFlNbUlqeXEwNFpXZ2xJTmJiQVZQZHZnNHlkQld1dk53b2FrQTg5MkN3dHRvWTlGeEFZdzZzOWRGRlNYbXl0WHR2QnpiMW5aNVRHczJtTHIyVTdXVllB?oc=5","date":"2024-09-27","type":"deal","source":"WSJ","summary":"Why Drug Distributors Are Buying Cancer Specialists - WSJ","headline":"Why Drug Distributors Are Buying Cancer Specialists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNcDhfeTdPRTNiajRzMDhqYWZYSFdRXzVJRnR6SDVUd3c0UFd4MHJVOHNCNndSU3BMakJPZGFMZjBjRGxfUDNOTENXR182bXZub2xxQS16TnJGR0VzVXczcVF1M3lVZ2szbkY2ZlZ0VXNkSVo1Rl9wQVJueFd5clY3cUM2Q1RfMlZhb0NhQW1YNC1KX2JDb25TWTNKb1Q?oc=5","date":"2024-03-05","type":"pipeline","source":"Eyes On Eyecare","summary":"Amring Pharmaceuticals is now Nordic Pharma - Eyes On Eyecare","headline":"Amring Pharmaceuticals is now Nordic Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOdWdINkNlQmNMMjdlNmU3RjEzOV8tX3JlZW1DMEtad3JTcTB4V2o2dkVobzhpZk1xUWd5eDJyTEJyLTlEVmJPMmZUVUZMR3dGa2dKc2pHS2IySjF0YnpPTnhBT0lqWkpDU2xUZzhiTDE1NVBndkFNaXg1cXhmcTZ5ay1nYXEwWXFoUU40dHZrQThMdFJxekhxZEdzV1lac2lOVjdZNkllT2JjSEZ4YVE?oc=5","date":"2023-10-25","type":"pipeline","source":"The American Journal of Managed Care® (AJMC®)","summary":"Dr Eric Donnenfeld Talks Utilization, Accessibility of Lotilaner Ophthalmic Solution - The American Journal of Managed Care® (AJMC®)","headline":"Dr Eric Donnenfeld Talks Utilization, Accessibility of Lotilaner Ophthalmic Solution - The American Journal of Managed C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNODRtRWhDSk5LYTh2UXdfQ0ZkWjg5YjV0dERaTG1uWUduVHIzY1pGRGc3U1RyUGpDMEdlcWNYVjFzWTFBUnVnVDhVOW8yOEpkZkpXN01fZ3lSdkdzckY2UmlKOXFtSlo3NG9DNnpVR0xIdmtBNDhqdlVCTXM2cEw0VExYVTFZVDFuLXcwOEJ3NWpPZ3FkRV9KUEZTUFJZOUpRcWRHNnJWWk5YVVh4TFdwR0VFTWk1bTVJT01Rbkh6TFFaamRDa01vbEkzMEVzdw?oc=5","date":"2023-06-21","type":"regulatory","source":"Ophthalmology Times","summary":"Dry eye paradise: FDA green-lights Miebo as first and only eye drop approved for the condition - Ophthalmology Times","headline":"Dry eye paradise: FDA green-lights Miebo as first and only eye drop approved for the condition","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNOUZDRlRYSWJSVmZTbXRIWmd2WFlVMldnWm41RW8yNUkxdklWWHVIeXFNV29BRkdZUmRTU0l4MjlIQjhUYml6bjZqRGhzR0JOVlBNdGdlZ2d1Q2NXbjZUMzFzaEFtX1Z6dWx2V3pIMHlMYU5uOThOWmVpazhGeEZEZ2UxTkF0anZJUllpYXFMdXVYZU1PSW1mOEZZNFRFcXJlMGpNNUhUTHNKSlFJTnYzODBWRkFnUHFYd1hz?oc=5","date":"2023-03-29","type":"pipeline","source":"The Boston Globe","summary":"Waltham biotech’s vision loss drug helps slow a form of macular degeneration - The Boston Globe","headline":"Waltham biotech’s vision loss drug helps slow a form of macular degeneration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOc2Vibk1tSzVJNG9RbVhaVkxDcWdMNWZOQjFLTzRjdGpvV3czR1pwcmZGTVVqeUpJdVJwOXhnMEUtMG5BNlJHblNLWFJWNS1JYnFXRGZyVzhIc0V6TzNNUlYyUnlwbHdMY0ZCNHBGU1N5bHh4OUx2bGFiNjdEWjVzT195NUpOakZCNENCNlpkVTY0MDc0dGY2S21vX3FGc1RBYnN5T1drSUROMVNqekxXcXItT2ZsZWQwTERjdDRUNDFoT21xRDktTTVB?oc=5","date":"2023-01-05","type":"pipeline","source":"businesswire.com","summary":"Harrow Announces Availability of Fortisite™ Formulations for In-Office Use - businesswire.com","headline":"Harrow Announces Availability of Fortisite™ Formulations for In-Office Use","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE55cnRrYVNJWGNieTR3M01nZUN2V3NfdnlUZGMwOW5Bc1dVc1RuWmhaeEFyS3c5TjlWYlZ6cjVTNTFuZEdvSjBoUm9YY08tNE9LMDVxSUtYRnpQcUZZQUItV2NIRUZreEZ6UTRzRDNBa3k2UUlCUWxzUQ?oc=5","date":"2022-04-08","type":"patent","source":"EyeWorld","summary":"First generic cyclosporine for dry eye - EyeWorld","headline":"First generic cyclosporine for dry eye","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYmFGZGgta3FtV2FmSC1ncXN6YWd3eEVINXFfOFdTcWtHQkhtc2Q5Q1hFQ1JYMUtSVllJX0RzeHgzS3daRlBvM0RSZ2RuWVV3YnNvOVpfUGREMkxRN1ZwT1lHczMwenp4NXBxX2lxZ1RWMll0d3ZmTWtHemg1OUEyY0N3?oc=5","date":"2021-11-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Presbyopia-Correcting Eyedrops Move Ahead - American Academy of Ophthalmology","headline":"Presbyopia-Correcting Eyedrops Move Ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxQdlBvcFUyLXFURF9HTWtubk9vYTNPV3ZnT3hheFBaOFFES25jZDZpakdxUU5IblJiTm13ZTduUjJBbmN5RTVpSlF1ZWk4d3Z3bHpPWm1WWVBGUWdCd2VYNmE2a1M4d3ZaX2VNb2lQcXNvVGMzMi1kNHpUTXVWLVN3Z3E1QzExLTNXRDJRNDhTSklwazlRU2paVFdtUW9xTk5LR1p3ZmVqYUFjOXhVRDFIOWd4S0dlRnRfb2RsZzBrb0lYR3FrOG9Pbk05WE9mbWYyUEh1VXM1MGMtV0w4UDF4Sk52MUtKMEhtd0xMS3RpS0FBdm05SnRiRFlVYjAzcHBoQ3lnbmY0M1RvMkVqV3NN?oc=5","date":"2019-02-11","type":"pipeline","source":"prnewswire.com","summary":"Ophthalmic Consultants of Long Island (OCLI), one of the largest independent ophthalmology practices in the region, joins Healthix - prnewswire.com","headline":"Ophthalmic Consultants of Long Island (OCLI), one of the largest independent ophthalmology practices in the region, join","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNM0tXUFk0M3FPdnVtYVFJVmpuUEoxTmYyMFk0RzhPMzFxX2dxU2tFczhRX0gxcG1ud2VhcnR6UkVZbmc0cF9kNG83SFJ2cU9VVlNFQnZ5SGl1b3ptLUVVcjNUSElYUENIVnpmYzdUeWpzOEVIa0U2MElKcng1bE5EMm5rbGNjT3I3TlBxamtWZDJCQQ?oc=5","date":"2013-09-01","type":"pipeline","source":"Healio","summary":"Drug contamination cases spur scrutiny of compounding pharmacies - Healio","headline":"Drug contamination cases spur scrutiny of compounding pharmacies","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}